| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-05 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.3 | 0.0004 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |